Free tool
FAERS Monitor: Nexium
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 022101 or its brand name (Nexium, Esomeprazole Magnesium). Reports on generic versions are filed under their own applications.
Reports
184,794
Serious
125,906
68% of reports
Hospitalization
49,903
Death reported
14,871
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- chronic kidney disease33,708
- acute kidney injury17,592
- renal failure14,997
- drug ineffective11,529
- gastrooesophageal reflux disease11,038
- drug dose omission10,970
- nausea10,406
- end stage renal disease9,816
- renal injury8,915
- pain8,591
- diarrhoea7,953
- malaise7,946
- fatigue7,299
- headache6,995
- dyspnoea6,906
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 2,032 |
| 2005 | 2,746 |
| 2006 | 3,529 |
| 2007 | 4,467 |
| 2008 | 5,251 |
| 2009 | 6,620 |
| 2010 | 8,243 |
| 2011 | 13,211 |
| 2012 | 22,370 |
| 2013 | 7,117 |
| 2014 | 7,345 |
| 2015 | 10,485 |
| 2016 | 10,084 |
| 2017 | 8,080 |
| 2018 | 21,309 |
| 2019 | 21,821 |
| 2020 | 7,600 |
| 2021 | 6,011 |
| 2022 | 4,385 |
| 2023 | 3,285 |
| 2024 | 3,034 |
| 2025 | 3,532 |
| 2026 | 2,234 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,869,365 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| end stage renal diseaseSignal | 9,816 | 131.3 | 127.6 | 587,427 |
| chronic kidney diseaseSignal | 33,708 | 89.9 | 88.7 | 1,655,708 |
| renal injurySignal | 8,915 | 48.3 | 47.2 | 289,802 |
| gastrooesophageal reflux diseaseSignal | 11,038 | 17.9 | 17.6 | 152,794 |
| acute kidney injurySignal | 17,592 | 14.7 | 14.4 | 199,512 |
| renal failureSignal | 14,997 | 14.4 | 14.1 | 166,432 |
| drug dose omissionSignal | 10,970 | 8.0 | 7.9 | 63,414 |
| malaiseSignal | 7,946 | 2.1 | 2.0 | 4,478 |
| pain | 8,591 | 1.6 | 1.6 | 1,964 |
| nausea | 10,406 | 1.5 | 1.5 | 1,796 |
| diarrhoea | 7,953 | 1.4 | 1.4 | 955 |
| dyspnoea | 6,906 | 1.4 | 1.4 | 778 |
| headache | 6,995 | 1.3 | 1.2 | 417 |
| fatigue | 7,299 | 1.1 | 1.0 | 32 |
| drug ineffective | 11,529 | 1.0 | 1.0 | 0 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.